| Net Cash Provided by (Used in) Operating Activities |
$496,000,000 |
USD |
-56% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$33,000,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$521,000,000 |
USD |
22% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
2,500,000,000 |
shares |
0% |
Q2 2024 |
Q2 2024 |
| Common Stock, Shares, Issued |
1,164,596,399 |
shares |
0.13% |
Q2 2024 |
Q2 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$8,000,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$15,000,000 |
USD |
-40% |
Q2 2024 |
Q2 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$2,748,000,000 |
USD |
-150% |
Q2 2024 |
Q2 2024 |
| Operating Lease, Liability, Current |
$42,000,000 |
USD |
-4.5% |
Q2 2024 |
Q2 2024 |
| Deferred Income Tax Expense (Benefit) |
$865,000,000 |
USD |
-12457% |
Q2 2024 |
Q2 2024 |
| Current Income Tax Expense (Benefit) |
$5,000,000 |
USD |
-124% |
Q2 2024 |
Q2 2024 |
| Depreciation, Depletion and Amortization |
$1,154,000,000 |
USD |
-7.8% |
Q2 2024 |
Q2 2024 |
| Share-based Payment Arrangement, Expense |
$32,000,000 |
USD |
39% |
Q2 2024 |
Q2 2024 |
| Interest Expense |
$141,000,000 |
USD |
-21% |
Q1 2024 |
Q1 2024 |